Blomia Tropicalis (Blo t 10) IgE Test · Blood

If you live in a warm, humid place and your asthma or stuffy nose keeps flaring even when standard dust mite tests look unremarkable, this antibody can help explain why. It zooms in on a single muscle-like protein inside the tropical dust mite called tropomyosin, a protein that also shows up in shrimp, cockroaches, and roundworms, which makes your immune system's reaction to it a useful clue to how widely allergic you are.

In a tropical asthma group from Cartagena, about 1 in 4 people tested positive for this specific antibody, and those positives clustered with markers of harder-to-control asthma, including more than four emergency visits per year. Knowing whether you carry this antibody can change which allergens you avoid, which immunotherapy mixture makes sense for you, and how seriously you take cross-reactivity with shellfish and other invertebrates.

What This Antibody Actually Measures

The test looks at IgE (immunoglobulin E, the antibody class your body uses for allergic reactions) directed against Blo t 10, a tropomyosin protein from Blomia tropicalis, a dust mite that thrives in tropical and subtropical homes. Tropomyosin is what scientists call a pan-allergen, meaning very similar versions appear across many unrelated creatures.

Because tropomyosins from different sources look nearly identical to your immune system, IgE to Blo t 10 tends to travel with IgE to other tropomyosins. In the Cartagena asthma group, IgE levels to Blo t 10, the Dermatophagoides house dust mite tropomyosin (Der p 10), and the Ascaris roundworm tropomyosin (Asc l 3) moved together very tightly, with a strong correlation between 0.57 and 0.85 (where 1.0 would mean they move in perfect lockstep). A positive result on this test is not really about Blomia alone, it is a window into how strongly your immune system reacts to this whole family of cross-reactive proteins.

This is a research and specialist-allergy marker, not a general screening test. It sits inside what allergists call component-resolved diagnostics, a more granular look at exactly which pieces of an allergen you react to. Standardized clinical cutoffs do not exist, so interpretation depends on your symptoms, your exposure, and the rest of your allergy workup.

Asthma and Allergic Airway Disease

The clearest signal in the human data ties this antibody to allergic asthma in tropical regions. In the Cartagena cohort, sensitization to Blo t 10 was found in 26.4% of asthmatic patients (95% CI 21.3 to 31.5), almost identical to the rates for the closely related tropomyosins Der p 10 (26.1%) and Asc l 3 (24.0%). The study treated the tropomyosin response as a group rather than isolating Blo t 10, and that group as a whole was associated with markers of more severe asthma, including frequent emergency visits.

Blo t 10 has also been included in molecular allergy panels for moderate-to-severe type 2 asthma in Spain, in asthmatic children and young adults in equatorial Africa, and in dust mite-allergic patients in Lithuania. Across these populations, it shows up as part of a wider mite component profile that helps explain why some patients react more strongly or to a broader range of invertebrates than others.

Compared to other Blomia components, Blo t 10 is not the dominant allergen in most regions. In Malaysian, Singaporean, and other Asian cohorts, the major components are Blo t 5, Blo t 21, Blo t 2, and Blo t 7. In one Taiwanese series, fewer than 10% of patients recognized Blo t 10. The clinical value of the Blo t 10 result is less about prevalence and more about what a positive tells you regarding cross-reactivity.

Cross-Reactivity With Shellfish, Cockroach, and Parasites

Because tropomyosin is so similar across species, a positive Blo t 10 result flags an immune pattern that can also react to tropomyosins in shrimp, crab, lobster, squid, cockroaches, and the Ascaris parasitic worm. This explains the well-documented overlap between dust mite allergy and shellfish allergy in many patients.

Knowing you are sensitized in this way reframes how you should think about your overall allergic profile. A positive Blo t 10 IgE is one of the better blood signals that your reactions are not limited to one species but reflect a broader response to this widely shared invertebrate protein.

What This Test Adds Beyond Standard Dust Mite Panels

Many routine allergy panels are built around the European-style house dust mites Dermatophagoides pteronyssinus and Dermatophagoides farinae. In tropical and subtropical regions, that design can miss patients whose immune system is reacting mainly or partly to Blomia tropicalis, which is dominant in those climates. Even when Blomia extract is tested, a single whole-extract result does not tell you which piece of the mite your immune system has latched onto.

Component-resolved testing for individual proteins like Blo t 10 separates species-specific sensitization, which usually shows up as IgE to Blo t 5 or Blo t 2, from broader cross-reactive sensitization driven by tropomyosin. That distinction matters for choosing an immunotherapy extract and for predicting reactions to foods and other invertebrates.

What Moves Your Result Over Time

Allergen-specific IgE is shaped by genetics, environment, and exposure, not by the day-to-day factors that move many other blood markers. Heritability of IgE to a Blomia antigen has been estimated at around 0.56 (where 1.0 would mean fully inherited), with stronger genetic patterns in male offspring than female.

Environmental influences matter too. In a Colombian birth cohort, unhygienic conditions in early childhood increased the odds of sensitization to Blomia components, while extremely high mite exposure was paradoxically linked with less intense IgE responses. Sensitization to parasitic worms also tracked with Blomia component sensitization as children aged.

Day-to-day confounders like time of day, fasting, kidney function, or BMI (body mass index) have not been shown to meaningfully shift Blo t 10 IgE. There is no published intra-individual coefficient of variation (a number describing how much the same person's result fluctuates from week to week) and no formal rule for how many tests to average before acting.

Tracking Your Trend

Because this is a newer, component-level test without standardized cutoffs, a single number tells you less than a trend. The most useful approach is to get a baseline, then retest if your symptoms change, your environment changes, or you start a multi-year course of allergen immunotherapy.

If you are using mite immunotherapy, expect changes to take time and to be modest in the blood. In a 6 to 12 month sublingual immunotherapy trial that mixed Dermatophagoides and Blomia extracts, total and mite-specific IgE did not change significantly compared to placebo, even though symptoms and medication use improved. Longer-term subcutaneous immunotherapy programs are generally expected to lower allergen-specific IgE eventually, often after an initial rise. A reasonable cadence is a baseline now, a follow-up at 6 to 12 months if your situation changes, and at least every year or two if you are in long-term treatment or your symptoms are evolving.

What an Unexpected Result Should Prompt You to Do

A positive Blo t 10 IgE is not a diagnosis on its own. It is a clue. The next step is to look at it alongside the rest of your allergy workup, especially species-specific markers like Blo t 5, Blo t 21, Blo t 2, Der p 1, Der p 2, and Der p 23, along with whole-extract IgE to Blomia and Dermatophagoides. That combination separates genuine, species-driven mite allergy from broad tropomyosin cross-reactivity.

If your Blo t 10 is positive and you also have unexplained reactions to shrimp, crab, or other shellfish, that combination is worth bringing to an allergist familiar with component-resolved diagnostics. If you have moderate-to-severe asthma or frequent flare-ups, the same allergist or a pulmonologist can use the tropomyosin pattern to inform medication choices and the design of any immunotherapy. The point is to use this result as a thread that pulls in the right specialist and the right companion tests, not to act on the number in isolation.

When Results Can Be Misleading

Two issues matter most when interpreting this test:

• Cross-reactivity with other tropomyosins: a positive Blo t 10 IgE may reflect a response originally triggered by a different invertebrate, such as shrimp, cockroach, or Ascaris roundworm, not necessarily Blomia itself. Without species-specific markers like Blo t 5 alongside, you cannot tell which exposure is driving your immune system.
• Assay and extract variability: different labs and manufacturers use different reagents, and commercial Blomia extracts vary in their content of major components. This can produce different values for the same person across labs, especially at the low end.